{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T16:22:09Z","timestamp":1787588529339,"version":"build-2736575974"},"reference-count":64,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2022,6,19]],"date-time":"2022-06-19T00:00:00Z","timestamp":1655596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Central nervous system infection with Coccidioides spp. is fatal if untreated and complications occur even when therapy is directed by experienced clinicians. We convened a panel of clinicians experienced in the management of coccidioidal meningitis to summarize current controversies and provide consensus for the management of this difficult infection.<\/jats:p>","DOI":"10.1093\/cid\/ciac478","type":"journal-article","created":{"date-parts":[[2022,6,19]],"date-time":"2022-06-19T17:40:26Z","timestamp":1655660426000},"page":"555-559","source":"Crossref","is-referenced-by-count":21,"title":["Controversies in the Management of Central Nervous System Coccidioidomycosis"],"prefix":"10.1093","volume":"75","author":[{"suffix":"III","given":"George R","family":"Thompson","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Division of Infectious Diseases and the Department of Medical Microbiology and Immunology, University of California-Davis Medical Center , Sacramento, California , USA"},{"name":"University of California-Davis Center for Valley Fever , Sacramento, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil M","family":"Ampel","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Mayo Clinic in Arizona , Phoenix, Arizona , USA"},{"name":"Department of Internal Medicine, Division of Infectious Diseases, University of Arizona College of Medicine , Tucson, Arizona , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janis E","family":"Blair","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Mayo Clinic in Arizona , Phoenix, Arizona , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fariba","family":"Donovan","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Infectious Diseases, University of Arizona College of Medicine , Tucson, Arizona , USA"},{"name":"Valley Fever Center for Excellence, University of Arizona College of Medicine-Tucson , Tucson, Arizona , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Fierer","sequence":"additional","affiliation":[{"name":"Division of Infectious Disease, Department of Medicine, University of California San Diego School of Medicine , La Jolla, California , USA"},{"name":"Infectious Diseases Section, VA Healthcare San Diego , San Diego, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John N","family":"Galgiani","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Infectious Diseases, University of Arizona College of Medicine , Tucson, Arizona , USA"},{"name":"Valley Fever Center for Excellence, University of Arizona College of Medicine-Tucson , Tucson, Arizona , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arash","family":"Heidari","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, David Geffen School of Medicine at UCLA, Kern Medical , Bakersfield, California , USA"},{"name":"Valley Fever Institute, Kern Medical Center , Bakersfield, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Royce","family":"Johnson","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, David Geffen School of Medicine at UCLA, Kern Medical , Bakersfield, California , USA"},{"name":"Valley Fever Institute, Kern Medical Center , Bakersfield, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley A","family":"Shatsky","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Good Samaritan Hospital , San Jose, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M","family":"Uchiyama","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Scripps Clinic and Scripps Green Hospital , La Jolla, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A","family":"Stevens","sequence":"additional","affiliation":[{"name":"California Institute for Medical Research , San Jose, California , USA"},{"name":"Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine , Stanford, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,6,19]]},"reference":[{"key":"2022091018183915600_ciac478-B1","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/clind\/16.2.247","article-title":"The natural history of coccidioidal meningitis: VA-Armed Forces cooperative studies, 1955\u20131958","volume":"16","author":"Vincent","year":"1993","journal-title":"Clin Infect Dis"},{"key":"2022091018183915600_ciac478-B2","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/978-1-4757-1712-9_11","volume-title":"Coccidioidomycosis: a text","author":"Kelly","year":"1980"},{"key":"2022091018183915600_ciac478-B3","doi-asserted-by":"crossref","first-page":"e112","DOI":"10.1093\/cid\/ciw360","article-title":"2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis","volume":"63","author":"Galgiani","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2022091018183915600_ciac478-B4","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/cid\/cir410","article-title":"Coccidioidomycosis during pregnancy: a review and recommendations for management","volume":"53","author":"Bercovitch","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2022091018183915600_ciac478-B5","doi-asserted-by":"crossref","first-page":"28","DOI":"10.7326\/0003-4819-119-1-199307010-00005","article-title":"Fluconazole therapy for coccidioidal meningitis. The NIAID-Mycoses Study Group","volume":"119","author":"Galgiani","year":"1993","journal-title":"Ann Intern Med"},{"key":"2022091018183915600_ciac478-B6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11910-018-0824-8","article-title":"Coccidioidal meningitis: a review on diagnosis, treatment, and management of complications","volume":"18","author":"Johnson","year":"2018","journal-title":"Curr Neurol Neurosci Rep"},{"key":"2022091018183915600_ciac478-B7","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/ijd.14238","article-title":"Cutaneous effects associated with fluconazole in patients treated for coccidioidomycosis","volume":"58","author":"Brewer","year":"2019","journal-title":"Int J Dermatol"},{"key":"2022091018183915600_ciac478-B8","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1093\/jac\/dky501","article-title":"Tolerability of long-term fluconazole therapy","volume":"74","author":"Davis","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"2022091018183915600_ciac478-B9","doi-asserted-by":"crossref","first-page":"e01384-18","DOI":"10.1128\/AAC.01384-18","article-title":"Examination of fluconazole-induced alopecia in an animal model and human cohort","volume":"63","author":"Thompson","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2022091018183915600_ciac478-B10","doi-asserted-by":"crossref","first-page":"305","DOI":"10.7326\/0003-4819-124-3-199602010-00004","article-title":"Is it ever safe to stop azole therapy for Coccidioides immitis meningitis?","volume":"124","author":"Dewsnup","year":"1996","journal-title":"Ann Intern Med"},{"issue":"Suppl 3","key":"2022091018183915600_ciac478-B11","doi-asserted-by":"crossref","first-page":"S318","DOI":"10.1093\/clinids\/12.Supplement_3.S318","article-title":"Pharmacokinetics and tissue penetration of fluconazole in humans","volume":"12","author":"Brammer","year":"1990","journal-title":"Rev Infect Dis"},{"key":"2022091018183915600_ciac478-B12","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/FTD.0b013e318167d0e0","article-title":"Therapeutic drug monitoring of antifungals: pharmacokinetic and pharmacodynamic considerations","volume":"30","author":"Smith","year":"2008","journal-title":"Ther Drug Monitor"},{"key":"2022091018183915600_ciac478-B13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/jac\/dkm389","article-title":"Antifungal serum concentration monitoring: an update","volume":"61","author":"Goodwin","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"2022091018183915600_ciac478-B14","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1128\/AAC.32.3.369","article-title":"Pharmacokinetics of fluconazole in cerebrospinal fluid and serum in human coccidioidal meningitis","volume":"32","author":"Tucker","year":"1988","journal-title":"Antimicrob Agents Chemother"},{"key":"2022091018183915600_ciac478-B15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bjid.2017.10.003","article-title":"Fluconazole levels in serum and cerebrospinal fluid according to daily dosage in patients with cryptococcosis and other fungal infections","volume":"22","author":"Schiave","year":"2018","journal-title":"Braz J Infect Dis"},{"key":"2022091018183915600_ciac478-B16","first-page":"509","article-title":"MR imaging of acute coccidioidal meningitis","volume":"20","author":"Erly","year":"1999","journal-title":"AJNR Am J Neuroradiol"},{"key":"2022091018183915600_ciac478-B17","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1086\/427215","article-title":"Neuroimaging as a guide to predict outcomes for patients with coccidioidal meningitis","volume":"40","author":"Arsura","year":"2005","journal-title":"Clin Infect Dis"},{"key":"2022091018183915600_ciac478-B18","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.2214\/AJR.12.9264","article-title":"Imaging spectrum of CNS coccidioidomycosis: prevalence and significance of concurrent brain and spinal disease","volume":"200","author":"Lammering","year":"2013","journal-title":"AJR Am J Roentgenol"},{"key":"2022091018183915600_ciac478-B19","doi-asserted-by":"crossref","first-page":"e02634-16","DOI":"10.1128\/AAC.02634-16","article-title":"Large-scale evaluation of in vitro amphotericin B, triazole, and echinocandin activity against coccidioides species from U.S. institutions","volume":"61","author":"Thompson","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2022091018183915600_ciac478-B20","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s11046-007-9018-7","article-title":"Antifungal susceptibility profiles of Coccidioides immitis and Coccidioides posadasii from endemic and non-endemic areas","volume":"163","author":"Ramani","year":"2007","journal-title":"Mycopathologia"},{"key":"2022091018183915600_ciac478-B21","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1128\/AAC.00332-06","article-title":"Comparison of itraconazole and fluconazole treatments in a murine model of coccidioidal meningitis","volume":"51","author":"Kamberi","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"2022091018183915600_ciac478-B22","doi-asserted-by":"crossref","first-page":"e02344-20","DOI":"10.1128\/AAC.02344-20","article-title":"Efficacy and associated drug exposures of isavuconazole and fluconazole in an experimental model of Coccidioidomycosis","volume":"65","author":"Kovanda","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"2022091018183915600_ciac478-B23","doi-asserted-by":"crossref","first-page":"108","DOI":"10.7326\/0003-4819-112-2-108","article-title":"Itraconazole therapy for chronic coccidioidal meningitis","volume":"112","author":"Tucker","year":"1990","journal-title":"Ann Intern Med"},{"key":"2022091018183915600_ciac478-B24","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1128\/AAC.48.6.2341.2004","article-title":"Successful use of voriconazole for treatment of Coccidioides meningitis","volume":"48","author":"Proia","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"2022091018183915600_ciac478-B25","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1093\/jac\/dki288","article-title":"Activity of posaconazole in the treatment of central nervous system fungal infections","volume":"56","author":"Pitisuttithum","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"2022091018183915600_ciac478-B26","doi-asserted-by":"crossref","first-page":"e02232-18","DOI":"10.1128\/AAC.02232-18","article-title":"Isavuconazole in the treatment of coccidioidal meningitis","volume":"63","author":"Heidari","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 1","key":"2022091018183915600_ciac478-B27","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1093\/mmy\/myy029","article-title":"Current concepts and future directions in the pharmacology and treatment of coccidioidomycosis","volume":"57","author":"Thompson","year":"2019","journal-title":"Med Mycol"},{"key":"2022091018183915600_ciac478-B28","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1128\/AAC.05275-11","article-title":"Fluoride excess in coccidioidomycosis patients receiving long-term antifungal therapy: an assessment of currently available triazoles","volume":"56","author":"Thompson","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"2022091018183915600_ciac478-B29","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1093\/cid\/ciz741","article-title":"Posaconazole serum drug levels associated with pseudohyperaldosteronism","volume":"70","author":"Nguyen","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2022091018183915600_ciac478-B30","doi-asserted-by":"crossref","first-page":"e00585-18","DOI":"10.1128\/AAC.00585-18","article-title":"Isavuconazole concentration in real-world practice: consistency with results from clinical trials","volume":"62","author":"Andes","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2022091018183915600_ciac478-B31","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/jac\/dkm264","article-title":"Efficacy of amphotericin B lipid complex in a rabbit model of coccidioidal meningitis","volume":"60","author":"Capilla","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"2022091018183915600_ciac478-B32","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1128\/AAC.01538-08","article-title":"Comparative efficacies of lipid-complexed amphotericin B and liposomal amphotericin B against coccidioidal meningitis in rabbits","volume":"53","author":"Clemons","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"2022091018183915600_ciac478-B33","first-page":"940","article-title":"Successful use of combination antifungal therapy in the treatment of coccidioides meningitis","volume":"98","author":"Antony","year":"2006","journal-title":"J Natl Med Assoc"},{"key":"2022091018183915600_ciac478-B34","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s11046-017-0240-7","article-title":"Liposomal amphotericin B as monotherapy in relapsed coccidioidal meningitis","volume":"183","author":"Stewart","year":"2018","journal-title":"Mycopathologia"},{"key":"2022091018183915600_ciac478-B35","volume-title":"Proceedings of the 60th Annual Coccidioidomycosis Study Group","author":"Kuberski","year":"2016"},{"key":"2022091018183915600_ciac478-B36","first-page":"339","article-title":"Coccidioidal meningitis: the use of amphotericin B in treatment","volume":"94","author":"Einstein","year":"1961","journal-title":"Calif Med"},{"key":"2022091018183915600_ciac478-B37","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/0002-9343(59)90046-4","article-title":"The use of amphotericin B in the treatment of coccidioidal disease","volume":"27","author":"Winn","year":"1959","journal-title":"Am J Med"},{"key":"2022091018183915600_ciac478-B38","first-page":"78","article-title":"The treatment of coccidioidal meningitis. The use of amphotericin B in a group of 25 patients","volume":"101","author":"Winn","year":"1964","journal-title":"Calif Med"},{"key":"2022091018183915600_ciac478-B39","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1001\/archinte.1986.00360220179029","article-title":"Survival improvement in coccidioidal meningitis by high-dose intrathecal amphotericin B","volume":"146","author":"Labadie","year":"1986","journal-title":"Arch Intern Med"},{"key":"2022091018183915600_ciac478-B40","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1053\/srin.2001.29298","article-title":"Intrathecal amphotericin in the management of coccidioidal meningitis","volume":"16","author":"Stevens","year":"2001","journal-title":"Semin Respir Infect"},{"key":"2022091018183915600_ciac478-B41","first-page":"519","article-title":"Intrathecal amphotericin B: a 60-year experience in treating coccidioidal meningitis","volume":"64","author":"Ho","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2022091018183915600_ciac478-B42","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1177\/028418516300100343","article-title":"Coccidioidal meningitis\u2013roentgen and pathologic analyses","volume":"1","author":"Newton","year":"1963","journal-title":"Acta Radiol Diagn (Stockh)"},{"key":"2022091018183915600_ciac478-B43","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1001\/archinte.1981.00340010067015","article-title":"Use of radiologic modalities in coccidioidal meningitis","volume":"141","author":"Stadalnik","year":"1981","journal-title":"Arch Intern Med"},{"key":"2022091018183915600_ciac478-B44","first-page":"1241","article-title":"MR findings in acute and chronic coccidioidomycosis meningitis","volume":"13","author":"Wrobel","year":"1992","journal-title":"AJNR Am J Neuroradiol"},{"key":"2022091018183915600_ciac478-B45","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1086\/313603","article-title":"Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. The NIAID Mycoses Study Group and AIDS Cooperative Treatment Groups","volume":"30","author":"Graybill","year":"2000","journal-title":"Clin Infect Dis"},{"key":"2022091018183915600_ciac478-B46","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0002-9343(91)90126-I","article-title":"Elevated cerebrospinal fluid pressures in patients with cryptococcal meningitis and acquired immunodeficiency syndrome","volume":"91","author":"Denning","year":"1991","journal-title":"Am J Med"},{"key":"2022091018183915600_ciac478-B47","doi-asserted-by":"crossref","first-page":"e883","DOI":"10.1016\/j.wneu.2020.03.135","article-title":"Shunt treatment for coccidioidomycosis-related hydrocephalus: a single-center series","volume":"138","author":"Morshed","year":"2020","journal-title":"World Neurosurg"},{"key":"2022091018183915600_ciac478-B48","doi-asserted-by":"crossref","first-page":"785","DOI":"10.3171\/2014.6.JNS14111","article-title":"Patient outcomes and surgical complications in coccidioidomycosis-related hydrocephalus: an institutional review","volume":"121","author":"Hardesty","year":"2014","journal-title":"J Neurosurg"},{"key":"2022091018183915600_ciac478-B49","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1086\/497596","article-title":"Coccidioidal meningitis","volume":"42","author":"Johnson","year":"2006","journal-title":"Clin Infect Dis"},{"key":"2022091018183915600_ciac478-B50","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/00006454-198305000-00009","article-title":"Amphotericin B and imidazole therapy for coccidioidal meningitis in children","volume":"2","author":"Harrison","year":"1983","journal-title":"Pediatr Infect Dis"},{"key":"2022091018183915600_ciac478-B51","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1093\/cid\/ciz052","article-title":"Coccidioidal meningitis in New York traced to Texas by fungal genomic analysis","volume":"69","author":"Barker","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2022091018183915600_ciac478-B52","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1093\/cid\/ciw861","article-title":"2017 Infectious Diseases Society of America\u2019s Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis","volume":"64","author":"Tunkel","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2022091018183915600_ciac478-B53","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1469-0691.2005.01349.x","article-title":"Comparison of three methodologies for the determination of pulmonary fungal burden in experimental murine aspergillosis","volume":"12","author":"Sheppard","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"2022091018183915600_ciac478-B54","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1086\/313643","article-title":"Hyphal forms in the central nervous system of patients with coccidioidomycosis","volume":"30","author":"Hagman","year":"2000","journal-title":"Clin Infect Dis"},{"key":"2022091018183915600_ciac478-B55","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/cid\/cix318","article-title":"Adjunctive corticosteroid therapy in the treatment of coccidioidal meningitis","volume":"65","author":"Thompson","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2022091018183915600_ciac478-B56","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1053\/srin.2001.29319","article-title":"Vasculitic complications associated with coccidioidal meningitis","volume":"16","author":"Williams","year":"2001","journal-title":"Semin Respir Infect"},{"key":"2022091018183915600_ciac478-B57","first-page":"1605","article-title":"Disseminated coccidioidomycosis complicated by vasculitis: a cause of fatal subarachnoid hemorrhage in two cases","volume":"20","author":"Erly","year":"1999","journal-title":"AJNR Am J Neuroradiol"},{"key":"2022091018183915600_ciac478-B58","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jocn.2020.08.007","article-title":"Cerebrovascular complications of coccidioidomycosis meningitis: case report and systematic review","volume":"80","author":"Phelps","year":"2020","journal-title":"J Clin Neurosci"},{"key":"2022091018183915600_ciac478-B59","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.wneu.2018.08.220","article-title":"Multiple intracranial aneurysms from coccidioidal meningitis: case report featuring aneurysm formation and spontaneous thrombosis with literature review","volume":"121","author":"Buchanan","year":"2019","journal-title":"World Neurosurg"},{"key":"2022091018183915600_ciac478-B60","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.3174\/ajnr.A5818","article-title":"Spinal coccidioidomycosis: MR imaging findings in 41 patients","volume":"39","author":"Crete","year":"2018","journal-title":"AJNR Am J Neuroradiol"},{"key":"2022091018183915600_ciac478-B61","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","article-title":"Clinical practice guidelines for the management of cryptococcal disease: 2010 Update by the Infectious Diseases Society of America","volume":"50","author":"Perfect","year":"2010","journal-title":"Clin Infect Dis"},{"key":"2022091018183915600_ciac478-B62","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/jof6010028","article-title":"Aspiring antifungals: review of current antifungal pipeline developments","volume":"6","author":"Gintjee","year":"2020","journal-title":"J Fungi (Basel)"},{"key":"2022091018183915600_ciac478-B63","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1007\/s40265-021-01611-0","article-title":"The antifungal pipeline: fosmanogepix, ibrexafungerp, olorofim, opelconazole, and rezafungin","volume":"81","author":"Hoenigl","year":"2021","journal-title":"Drugs"},{"key":"2022091018183915600_ciac478-B64","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1093\/jac\/dkab223","article-title":"Efficacy of nikkomycin Z in murine CNS coccidioidomycosis: modelling sustained-release dosing","volume":"76","author":"Sass","year":"2021","journal-title":"J Antimicrob Chemother"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciac478\/45033644\/ciac478.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/75\/4\/555\/45787040\/ciac478.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/75\/4\/555\/45787040\/ciac478.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,10]],"date-time":"2022-09-10T18:19:58Z","timestamp":1662833998000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/75\/4\/555\/6611484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,19]]},"references-count":64,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,6,19]]},"published-print":{"date-parts":[[2022,9,10]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciac478","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,8,15]]},"published":{"date-parts":[[2022,6,19]]}}}